Lab Testing Before Longevity or Peptide Discussions

Lab testing before peptide therapy or any longevity plan is not a formality; it is the step that decides whether optimization makes sense at all. Blood work identifies treatable disease, sets a baseline for measuring change, and flags conditions that make certain therapies unsafe. In my practice, no peptide or hormone conversation begins until I have seen recent labs.

Why Lab Testing Before Peptide Therapy Comes First

Many of the symptoms that bring people to a longevity clinic — fatigue, weight gain, poor sleep, low libido, slow recovery — are nonspecific. They can come from an underactive thyroid, iron deficiency, sleep apnea, depression, medication side effects, early diabetes or simply chronic under-recovery. A peptide does not fix any of these, and it can delay the diagnosis that would.

Labs serve three distinct purposes:

1. Diagnosis. Find conditions that need standard medical treatment first.
2. Safety screening. Identify reasons a specific compound should be avoided — for example, elevated blood sugar before considering a growth hormone–axis agent, or uncontrolled blood pressure before discussing PT-141.
3. Baseline. Record where you start, so any later change — good or bad — can be measured instead of guessed.

The Core Panel I Start With

The exact order depends on age, sex, history and goals, but most adults I see get some version of the following:

Foundation labs

• Complete blood count (CBC): anemia, infection patterns, and hematocrit — important if testosterone therapy is ever on the table.
• Comprehensive metabolic panel (CMP): kidney function, liver enzymes, electrolytes and fasting glucose.
• Lipid panel plus ApoB: ApoB counts the atherogenic particles directly and often tells a clearer story than LDL alone. Lipoprotein(a) is worth checking at least once in adulthood.
• HbA1c and fasting insulin: together these show both average glucose and how hard the pancreas is working to keep it there.
• Thyroid testing: TSH at minimum, with free T4 and sometimes free T3 when symptoms or results warrant it.
• Vitamin D, ferritin and B12: common, correctable deficiencies that mimic "low energy" problems.
• hs-CRP: a general marker of low-grade inflammation and cardiovascular risk.

For more depth on how I interpret these, see Metabolic Health Markers Every Adult Should Track and the companion article on inflammation biomarkers.

Targeted labs, based on the question

• Hormones in men: total and free testosterone (drawn in the morning, and confirmed on a second occasion before any diagnosis), LH, FSH, estradiol, SHBG and prolactin when indicated. PSA is discussed based on age and risk.
• Hormones in women: interpreted in the context of cycle timing, perimenopause and symptoms — a single estradiol value rarely answers the question by itself.
• IGF-1: relevant before and during any therapy that acts on the growth hormone axis, such as tesamorelin or sermorelin.
• Cancer screening status: not a blood test, but I want to know that age-appropriate screening is current before discussing any compound that influences growth signaling.

What Labs Can and Cannot Tell You

Labs are powerful, but they have limits, and an evidence-aware approach respects both sides.

What they do well: detect disease, quantify risk, and track change over time. A rising HbA1c, a falling ferritin or an IGF-1 that climbs above the age-appropriate range are concrete signals that change management.

What they do poorly: capture how you feel, predict how you will respond to an investigational compound, or define "optimal" for every person. Many "optimal ranges" circulating online are not grounded in outcome data. When I discuss a target, I try to be explicit about whether it comes from clinical guidelines, from observational associations, or simply from convention.

A single lab value is a snapshot. Trends across two or three measurements, drawn under similar conditions, are far more informative than any one result.

Common Findings That Change the Plan

Across many evaluations, certain patterns come up repeatedly and redirect the conversation away from peptides — at least initially:

• Undiagnosed prediabetes or insulin resistance. This becomes the priority, because it drives cardiovascular, liver and cognitive risk. It also argues against agents that can raise glucose.
• Low testosterone with an identifiable cause — poor sleep, obesity, opioid use, high prolactin or a pituitary issue. The cause needs evaluation before any hormone decision.
• Thyroid dysfunction presenting as fatigue, weight change or low mood.
• Iron deficiency or iron overload, both of which can cause fatigue and both of which require different management.
• Elevated liver enzymes suggesting fatty liver disease, alcohol effects or medication toxicity.
• Atherogenic lipid profiles that warrant a deeper cardiovascular risk discussion.

Sometimes the most valuable result of lab testing is learning that the foundation needs work and that no optimization therapy is appropriate yet.

How Often Should Labs Be Repeated?

There is no single schedule. A healthy adult with normal results may need a comprehensive panel once a year. Someone starting a new medication — or, under supervision, a therapy that affects hormones, glucose or growth signaling — usually needs follow-up labs within weeks to a few months, then periodically after that. The interval depends on the specific risk being monitored. I set it individually after the initial evaluation.

How Lab Review Works at Laeeq M.D.

At Laeeq M.D., the initial 60-minute consultation includes a review of your history, medications, supplements and any recent labs you bring. If you have results from your primary care physician, we use them and order only what is missing. If you have none, I order a panel tailored to your goals and history. A separate lab review visit is available when results return.

Patients are seen in person in Reston, VA, or virtually in Virginia, Maryland, Florida, Texas, California, Pennsylvania and Tennessee. Fees are listed on our pricing page, and new patients can find intake details on the new-patient page.

The Bottom Line

Lab testing before peptide therapy, hormone therapy or any longevity protocol protects you in two ways: it finds what needs standard medical care, and it gives a clear baseline for anything that follows. Optimization built on unmeasured assumptions is guesswork. Optimization built on a careful internal medicine evaluation is medicine. If you want to understand the broader philosophy, read The Lab-First Approach to Personalized Medicine.

Sources

• Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline — Journal of Clinical Endocrinology & Metabolism, 2018. https://pubmed.ncbi.nlm.nih.gov/29562364/
• Prediabetes and Type 2 Diabetes: Screening — U.S. Preventive Services Task Force recommendation summary (AAFP News), 2021. https://www.aafp.org/news/health-of-the-public/20210908uspstfdiabetes.html

Book a Consultation

If you are considering longevity care or peptide therapy, the right first step is a thorough evaluation with labs. Dr. Laeeq offers a 60-minute consultation, virtually or in person in Reston, to review your history and build a plan grounded in your results. Book a consultation to get started.

This article is for educational purposes and is not medical advice. Discuss any treatment with a licensed physician who knows your history.